- Home
- ADMA vs TENB Comparison
ADMA vs TENB Comparison
Compare ADMA & TENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- TENB
- Stock Information
- Founded
- ADMA 2004
- TENB 2002
- Country
- ADMA United States
- TENB United States
- Employees
- ADMA N/A
- TENB N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- TENB Computer Software: Prepackaged Software
- Sector
- ADMA Health Care
- TENB Technology
- Exchange
- ADMA Nasdaq
- TENB Nasdaq
- Market Cap
- ADMA 4.1B
- TENB 3.8B
- IPO Year
- ADMA N/A
- TENB 2018
- Fundamental
- Price
- ADMA $21.31
- TENB $31.44
- Analyst Decision
- ADMA Strong Buy
- TENB Buy
- Analyst Count
- ADMA 4
- TENB 18
- Target Price
- ADMA $22.50
- TENB $46.59
- AVG Volume (30 Days)
- ADMA 3.7M
- TENB 1.1M
- Earning Date
- ADMA 05-08-2025
- TENB 04-29-2025
- Dividend Yield
- ADMA N/A
- TENB N/A
- EPS Growth
- ADMA N/A
- TENB N/A
- EPS
- ADMA 0.81
- TENB N/A
- Revenue
- ADMA $426,454,000.00
- TENB $900,021,000.00
- Revenue This Year
- ADMA $18.45
- TENB $11.10
- Revenue Next Year
- ADMA $26.96
- TENB $8.71
- P/E Ratio
- ADMA $26.31
- TENB N/A
- Revenue Growth
- ADMA 65.16
- TENB 12.68
- 52 Week Low
- ADMA $6.01
- TENB $30.50
- 52 Week High
- ADMA $23.64
- TENB $49.18
- Technical
- Relative Strength Index (RSI)
- ADMA 60.16
- TENB 32.25
- Support Level
- ADMA $17.30
- TENB $30.50
- Resistance Level
- ADMA $22.25
- TENB $33.34
- Average True Range (ATR)
- ADMA 1.50
- TENB 1.35
- MACD
- ADMA 0.16
- TENB -0.05
- Stochastic Oscillator
- ADMA 83.62
- TENB 19.22
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About TENB Tenable Holdings Inc.
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.